FDA Approved: UPNEEQ — Original Application (RVL Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Upneeq (oxymetazoline hydrochloride ophthalmic solution) from RVL Pharmaceuticals as the first approved treatment for acquired ptosis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Blepharoptosis

Drugs mentioned

• Upneeq (oxymetazoline)

Snippet

ORIG AP for UPNEEQ (OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC)